Viridian Therapeutics Inc...

NASDAQ: VRDN · Real-Time Price · USD
18.53
0.09 (0.49%)
At close: Aug 15, 2025, 3:59 PM
18.54
0.05%
After-hours: Aug 15, 2025, 05:32 PM EDT

Viridian Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-269.95M -237.73M -129.87M -79.41M
Depreciation & Amortization
1.24M 522K 255K 120K
Stock-Based Compensation
42.15M 67.17M 19.77M 14.46M
Other Working Capital
9.57M 2.62M 4.44M 69K
Other Non-Cash Items
-15.72M -4.71M 54K 7.49M
Deferred Income Tax
n/a n/a n/a 1.04M
Change in Working Capital
9.6M -9.43M 15.96M 1.72M
Operating Cash Flow
-232.32M -184.17M -93.84M -54.58M
Capital Expenditures
-511K -898K -797K -338K
Cash Acquisitions
n/a n/a 114.33M 79K
Purchase of Investments
n/a -407.88M -223.26M -188.43M
Sales Maturities Of Investments
n/a 314.53M 108.94M 114.4M
Other Investing Acitivies
-228.65M n/a -114.33M -73.95M
Investing Cash Flow
-228.65M -94.25M -115.13M -74.29M
Debt Repayment
n/a 15M 5M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 9.41M -446K n/a
Financial Cash Flow
457.74M 225.67M 322.24M 125.28M
Net Cash Flow
-3.23M -52.75M 113.28M -3.6M
Free Cash Flow
-232.83M -185.07M -94.64M -54.92M